BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28691277)

  • 1. Crotalus atrox Venom Exposed to Carbon Monoxide Has Decreased Fibrinogenolytic Activity In Vivo in Rabbits.
    Nielsen VG
    Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):82-86. PubMed ID: 28691277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the Rabbit as an In Vitro and In Vivo Model to Assess the Effects of Fibrinogenolytic Activity of Snake Venom on Coagulation.
    Nielsen VG; Sánchez EE; Redford DT
    Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):157-164. PubMed ID: 28696521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron and carbon monoxide attenuate degradation of plasmatic coagulation by Crotalus atrox venom.
    Nielsen VG; Boyer LV
    Blood Coagul Fibrinolysis; 2016 Jul; 27(5):506-10. PubMed ID: 26575491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron protects porcine plasma coagulation kinetics from degradation by Crotalus atrox venom.
    Olver CS; Nielsen VG
    Biometals; 2017 Oct; 30(5):677-683. PubMed ID: 28726133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of purified human fibrinogen modified with carbon monoxide and iron on coagulation in rabbits injected with Crotalus atrox venom.
    Nielsen VG
    J Thromb Thrombolysis; 2017 Nov; 44(4):481-488. PubMed ID: 28889321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon monoxide releasing molecule enhances coagulation and decreases fibrinolysis in canine plasma exposed to Crotalus viridis venom in vitro and in vivo.
    Johnson TE; Wells RJ; Bell A; Nielsen VG; Olver CS
    Basic Clin Pharmacol Toxicol; 2019 Oct; 125(4):328-336. PubMed ID: 31059181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron and carbon monoxide attenuate Crotalus atrox venom-enhanced tissue-type plasminogen activator-initiated fibrinolysis.
    Nielsen VG; Boyer LV; Matika RW; Amos Q; Redford DT
    Blood Coagul Fibrinolysis; 2016 Jul; 27(5):511-6. PubMed ID: 26575490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Iron and Carbon Monoxide on Fibrinogenase-like Degradation of Plasmatic Coagulation by Venoms of Six Agkistrodon Species.
    Nielsen VG; Redford DT; Boyle PK
    Basic Clin Pharmacol Toxicol; 2016 May; 118(5):390-5. PubMed ID: 26467642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ruthenium-based antivenom attenuates Crotalus atrox venom mediated coagulopathy in rabbits.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2024 Jun; 35(4):167-172. PubMed ID: 38477828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CatroxMP-II: a heme-modulated fibrinogenolytic metalloproteinase isolated from Crotalus atrox venom.
    Suntravat M; Langlais PR; Sánchez EE; Nielsen VG
    Biometals; 2018 Aug; 31(4):585-593. PubMed ID: 29761254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of iron and carbon monoxide on fibrinogenase-like degradation of plasmatic coagulation by venoms of four Crotalus species.
    Nielsen VG; Redford DT; Boyle PK
    Blood Coagul Fibrinolysis; 2017 Jan; 28(1):34-39. PubMed ID: 26845427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct Inhibitory Effects of Carbon Monoxide on Six Venoms Containing Fibrinogenolytic Metalloproteinases.
    Nielsen VG; Losada PA
    Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):207-212. PubMed ID: 27546530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron and carbon monoxide prevent degradation of plasmatic coagulation by thrombin-like activity in rattlesnake venom.
    Nielsen VG
    Hum Exp Toxicol; 2016 Oct; 35(10):1116-22. PubMed ID: 26666988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon monoxide inhibits the anticoagulant activity of Mojave rattlesnake venoms type A and B.
    Nielsen VG
    J Thromb Thrombolysis; 2019 Aug; 48(2):256-262. PubMed ID: 31124031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in vitro and in vivo in the rabbit.
    Nielsen VG; Arkebauer MR; Wasko KA; Malayaman SN; Vosseller K
    Blood Coagul Fibrinolysis; 2012 Jan; 23(1):104-7. PubMed ID: 22143252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbon monoxide releasing molecule-2 inhibition of snake venom thrombin-like activity: novel biochemical "brake"?
    Nielsen VG; Bazzell CM
    J Thromb Thrombolysis; 2017 Feb; 43(2):203-208. PubMed ID: 27787696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon monoxide inhibits the anticoagulant activity of phospholipase A
    Nielsen VG
    J Thromb Thrombolysis; 2019 Jan; 47(1):73-79. PubMed ID: 30374703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon Monoxide-Releasing Molecule Enhances Coagulation and Decreases Fibrinolysis in Normal Canine Plasma.
    Donaghy D; Yoo S; Johnson T; Nielsen V; Olver C
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):257-262. PubMed ID: 29577635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased snake venom metalloproteinase effects via inhibition of enzyme and modification of fibrinogen.
    Nielsen VG; Cerruti MA; Valencia OM; Amos Q
    Biometals; 2016 Oct; 29(5):913-9. PubMed ID: 27492573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of canine whole blood with the addition of Crotalus atrox (Western Diamondback Rattlesnake) venom and antivenom using thromboelastography.
    Altemus Bailey SR; Lyon SD; Gilliam LL
    J Vet Emerg Crit Care (San Antonio); 2022 Sep; 32(5):616-622. PubMed ID: 35712887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.